drugset / Trial / NCT05317767
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
RandomizedParallel-groupDouble-blindDiagnostic
Summary
Comparative assessment of the tolerability, safety and immunogenicity of the Flu-M vaccine vs. the Ultrix® vaccine by single vaccination of children aged 6 to 17 years.
Timeline
- Start
- 2020-02-10
- Primary completion
- 2020-07-05
- Completion
- 2020-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flu-M | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Ultrix | Vaccine | 0.5 ml | Intramuscular |